ARTICLE | Company News
BAC B.V., Genmab deal
October 18, 2010 7:00 AM UTC
BAC B.V., Naarden, The Netherlands Genmab A/S (CSE:GEN), Copenhagen, Denmark Business: Antibodies BAC completed the development and a feasibility study of its CaptureSelect custom affinity ligands to...